Search

How good ideas become great products: in conversation with three medical innovators

Ever had a great idea for an innovation that would significantly improve your practice, but wondered how to go about developing it? Lucy Dalton interviewed three consultant ENT surgeons-come-successful innovators (one international, one novice and one experienced) who explain what...

Redeployment of audiologists during COVID-19

As the demand on intensive therapy units in the NHS increased, volunteers from the audiology profession stepped in to support colleagues. Here, they share their experiences of caring on the frontline. Redefining normal: from outpatients to the ICU By Emilee...

Family-centred early intervention: supporting a call to action

Family-centred care for young children is a commonly used but frequently under-appreciated approach in audiology. Prof Moodie discusses how we can take positive action to improve our approach to families in ways that make a meaningful difference in their lives....

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...

The future of inner ear drug delivery

The techniques for delivering drugs to the inner ear system are evolving. Jeffrey Harris considers the myths, the facts and the potential for drug delivery innovations and how they can improve tomorrow’s hearing outcomes. The inner ear’s delicate membranous structure,...

Making audiology work during COVID-19 and beyond

‘New normal’ is another phrase that has become synonymous with this pandemic. In this article, consideration for ‘low-touch’ and ‘no touch’ audiological pathways are described for adoption as the ‘new normal’ for hearing healthcare. The COVID-19 crisis has ushered in...

Genetic research on hereditary hearing loss and clinical application in the Chinese population

Congenital deafness in China affects more people than the entire population of Australia. Prof Wang give us a comprehensive insight into one of the main congenital disabilities in China, looking into the causes of deafness and the benefits of genetic...

Reflections on educational gatherings in the COVID era

The COVID pandemic has brought disruption and uncertainty for the organisers of medical conferences. ENT and audiology have always thrived on a healthy exchange of views and the sharing of knowledge across subspecialties and across national boundaries. Ray Clarke asked...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...